Cargando...
Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix Cancer
Uterine cervix cancers pose therapeutic challenges because of an overactive ribonucleotide reductase, which provides on-demand deoxyribonucleotides for DNA replication or for a DNA damage repair response. Ribonucleotide reductase overactivity bestows cancer cell resistance to the effects of radiothe...
Gardado en:
| Publicado en: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6607970/ https://ncbi.nlm.nih.gov/pubmed/31297338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00560 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|